ATE461925T1 - Benzisoxazolpiperidinverbindungen und verfahren zu deren anwendung - Google Patents

Benzisoxazolpiperidinverbindungen und verfahren zu deren anwendung

Info

Publication number
ATE461925T1
ATE461925T1 AT06751667T AT06751667T ATE461925T1 AT E461925 T1 ATE461925 T1 AT E461925T1 AT 06751667 T AT06751667 T AT 06751667T AT 06751667 T AT06751667 T AT 06751667T AT E461925 T1 ATE461925 T1 AT E461925T1
Authority
AT
Austria
Prior art keywords
benzisoxazolepiperidine
compounds
compositions
methods
invention includes
Prior art date
Application number
AT06751667T
Other languages
English (en)
Inventor
James White
Daniel Coughlin
Dale Edgar
Michael Solomon
David Hangauer
Kazumi Shiosaki
Original Assignee
Hypnion Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hypnion Inc filed Critical Hypnion Inc
Priority claimed from PCT/US2006/016059 external-priority patent/WO2006116615A1/en
Application granted granted Critical
Publication of ATE461925T1 publication Critical patent/ATE461925T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
AT06751667T 2005-04-26 2006-04-26 Benzisoxazolpiperidinverbindungen und verfahren zu deren anwendung ATE461925T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67520205P 2005-04-26 2005-04-26
PCT/US2006/016059 WO2006116615A1 (en) 2005-04-26 2006-04-26 Benzisoxazole piperazine compounds and methods of use thereof

Publications (1)

Publication Number Publication Date
ATE461925T1 true ATE461925T1 (de) 2010-04-15

Family

ID=36754209

Family Applications (2)

Application Number Title Priority Date Filing Date
AT06751665T ATE459621T1 (de) 2005-04-26 2006-04-26 Benzisoxazolpiperidinverbindungen und verfahren zu deren anwendung
AT06751667T ATE461925T1 (de) 2005-04-26 2006-04-26 Benzisoxazolpiperidinverbindungen und verfahren zu deren anwendung

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT06751665T ATE459621T1 (de) 2005-04-26 2006-04-26 Benzisoxazolpiperidinverbindungen und verfahren zu deren anwendung

Country Status (15)

Country Link
US (3) US8129410B2 (de)
EP (2) EP1877390B1 (de)
JP (2) JP5049267B2 (de)
CN (1) CN101208314B (de)
AT (2) ATE459621T1 (de)
AU (1) AU2006239302B2 (de)
CA (2) CA2606473C (de)
CY (1) CY1110026T1 (de)
DE (2) DE602006012650D1 (de)
DK (1) DK1877390T3 (de)
ES (2) ES2341127T3 (de)
MX (1) MX2007013352A (de)
PL (1) PL1877390T3 (de)
PT (1) PT1877390E (de)
WO (1) WO2006116614A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0412263B1 (pt) 2003-07-22 2019-10-15 Arena Pharmaceuticals, Inc. Derivados de diaril e aril heteroaril uréia, uso e composição farmacêutica contendo os mesmos, bem como processo para preparação da dita composição
PE20061130A1 (es) 2004-11-19 2007-01-05 Arena Pharm Inc Derivados de 3-fenil-pirazol como moduladores del receptor de serotonina 5-ht2a
PL1877390T3 (pl) * 2005-04-26 2010-08-31 Hypnion Inc Związki benzizoksazolopiperazynowe i sposoby ich stosowania
EP3395816A1 (de) 2006-05-18 2018-10-31 Arena Pharmaceuticals, Inc. Ether, sekundäre amine und derivate davon als modulatoren des 5-ht2a-serotonin-rezeptors zur behandlung damit zusammenhängender erkrankungen
WO2007136703A1 (en) 2006-05-18 2007-11-29 Arena Pharmaceuticals, Inc. Primary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
EA016675B1 (ru) 2006-05-18 2012-06-29 Арена Фармасьютикалз, Инк. Способы получения фенилпиразолов и кристаллическая форма производного фенилпиразола
US7762006B2 (en) * 2006-06-14 2010-07-27 Siestamed, Technologies Medical equipment drying device
TWI415845B (zh) 2006-10-03 2013-11-21 Arena Pharm Inc 用於治療與５-ｈｔ2ａ血清素受體相關聯病症之作為５-ｈｔ2ａ血清素受體之調節劑的吡唑衍生物
US9220837B2 (en) * 2007-03-19 2015-12-29 Insuline Medical Ltd. Method and device for drug delivery
US8622991B2 (en) 2007-03-19 2014-01-07 Insuline Medical Ltd. Method and device for drug delivery
WO2009081262A1 (en) 2007-12-18 2009-07-02 Insuline Medical Ltd. Drug delivery device with sensor for closed-loop operation
MX2009010000A (es) * 2007-03-19 2010-03-17 Insuline Medical Ltd Dispositivo para el suministro de farmaco.
EP2136863A2 (de) * 2007-03-19 2009-12-30 Insuline Medical Ltd. Vorrichtung zur abgabe von arzneimitteln und relevante verbindungen
WO2009023253A2 (en) 2007-08-15 2009-02-19 Arena Pharmaceuticals Inc. IMIDAZO[L,2-α]PYRIDINE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
WO2009123714A2 (en) 2008-04-02 2009-10-08 Arena Pharmaceuticals, Inc. Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor
WO2009126830A2 (en) * 2008-04-09 2009-10-15 Surmodics, Inc. Delivery of nucleic acid complexes from materials including negatively charged groups
SG176464A1 (en) * 2008-05-09 2011-12-29 Agency Science Tech & Res Diagnosis and treatment of kawasaki disease
US9126946B2 (en) 2008-10-28 2015-09-08 Arena Pharmaceuticals, Inc. Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)urea and crystalline forms related thereto
DK2364142T3 (en) 2008-10-28 2018-04-30 Arena Pharm Inc COMPOSITIONS OF A 5-HT2A SEROTONIN RECEPTOR MODULATOR USED FOR TREATMENT OF DISEASES RELATED TO THE RECEPTOR
BRPI0916125A2 (pt) 2008-11-07 2015-11-03 Insuline Medical Ltd "dispositivo de tratamento"
US8555875B2 (en) * 2008-12-23 2013-10-15 Map Pharmaceuticals, Inc. Inhalation devices and related methods for administration of sedative hypnotic compounds
WO2011075596A1 (en) 2009-12-18 2011-06-23 Arena Pharmaceuticals, Inc. Crystalline forms of certain 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
US8565107B2 (en) 2010-09-24 2013-10-22 Hand Held Products, Inc. Terminal configurable for use within an unknown regulatory domain
RU2017145976A (ru) 2015-06-12 2019-07-15 Аксовант Сайенсиз Гмбх Производные диарил- и арилгетероарилмочевины, применимые для профилактики и лечения нарушения поведения во время REM-фазы сна
KR20180064373A (ko) 2015-07-15 2018-06-14 엑소반트 사이언시즈 게엠베하 신경퇴행성 질환과 관련된 환각의 예방 및 치료에 유용한 5-ht2a 세로토닌 수용체의 조절자로서의 다이아릴 및 아릴헤테로아릴 우레아 유도체
MX2022007947A (es) * 2019-12-24 2022-07-27 Sumitomo Pharma Co Ltd Derivado de amida de acido alifatico.

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3331541A (en) * 1965-06-07 1967-07-18 Bell & Howell Co Sprocketless projector
US5364866A (en) 1989-05-19 1994-11-15 Hoechst-Roussel Pharmaceuticals, Inc. Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analetics
US5776963A (en) 1989-05-19 1998-07-07 Hoechst Marion Roussel, Inc. 3-(heteroaryl)-1- (2,3-dihydro-1h-isoindol-2-yl)alkyl!pyrrolidines and 3-(heteroaryl)-1- (2,3-dihydro-1h-indol-1-yl)alkyl!pyrrolidines and related compounds and their therapeutic untility
FR2654104B1 (fr) 1989-11-07 1992-01-03 Adir Nouveaux derives du 1,2-benzisoxazole, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
DK60593D0 (da) 1993-05-26 1993-05-26 Novo Nordisk As Kemiske forbindelser, deres fremstilling og anvendelse
FR2742052B1 (fr) * 1995-12-12 1998-04-10 Esteve Labor Dr Utilisation des derives 1-(4-(4-aryl (ou heteroaryl)-1-piper azinyl)-buty)-1h-azole pour le traitement de la depression, des troubles obsessifs compulsifs, l'apnee du sommeil, les dysfonctions sexuelles, l'emese et le mal des transports
ZA9610738B (en) 1995-12-22 1997-06-24 Warner Lambert Co Subtype selective nmda receptor ligands and the use thereof
WO1997049698A1 (en) 1996-06-21 1997-12-31 Glaxo Group Limited Piperidine acetic acid derivatives and their use in the treatment of thrombotic disorders
DE69829317T2 (de) * 1997-12-25 2006-04-06 Meiji Seika Kaisha Ltd. Tetrahydrobenzindol-derivate
US6331541B1 (en) 1998-12-18 2001-12-18 Soo S. Ko N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
US6605623B1 (en) 1998-12-18 2003-08-12 Bristol-Myers Squibb Pharma Co. N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
ES2165274B1 (es) * 1999-06-04 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de indolilpiperidina como agentes antihistaminicos y antialergicos.
ATE313534T1 (de) 2001-02-16 2006-01-15 Aventis Pharma Inc Heterocyclische substituierte carbonyl derivate und ihre verwendung als dopamin d3 rezeptor liganden
GB0117577D0 (en) * 2001-02-16 2001-09-12 Aventis Pharm Prod Inc Novel heterocyclic substituted carbonyl derivatives and their use as dopamine D receptor ligands
US7355042B2 (en) 2001-10-16 2008-04-08 Hypnion, Inc. Treatment of CNS disorders using CNS target modulators
ES2201899B1 (es) * 2002-04-01 2005-06-01 Almirall Prodesfarma, S.A. Derivados de la azaindolilpiperidina como agentes antihistaminicos y antialergicos.
PL1877390T3 (pl) 2005-04-26 2010-08-31 Hypnion Inc Związki benzizoksazolopiperazynowe i sposoby ich stosowania

Also Published As

Publication number Publication date
US20070004752A1 (en) 2007-01-04
DE602006012650D1 (de) 2010-04-15
CY1110026T1 (el) 2015-01-14
PT1877390E (pt) 2010-05-31
DK1877390T3 (da) 2010-05-31
US20090163514A1 (en) 2009-06-25
EP1877405A1 (de) 2008-01-16
JP2008539267A (ja) 2008-11-13
AU2006239302A1 (en) 2006-11-02
ES2340066T3 (es) 2010-05-28
US20080214539A1 (en) 2008-09-04
AU2006239302B2 (en) 2011-07-07
EP1877405B1 (de) 2010-03-03
CA2606471A1 (en) 2006-11-02
CN101208314A (zh) 2008-06-25
US7494998B2 (en) 2009-02-24
WO2006116614A1 (en) 2006-11-02
CA2606471C (en) 2014-02-11
JP5049267B2 (ja) 2012-10-17
CA2606473A1 (en) 2006-11-02
ATE459621T1 (de) 2010-03-15
US8088778B2 (en) 2012-01-03
ES2341127T3 (es) 2010-06-15
US8129410B2 (en) 2012-03-06
EP1877390B1 (de) 2010-03-24
JP2008539268A (ja) 2008-11-13
PL1877390T3 (pl) 2010-08-31
CA2606473C (en) 2013-08-13
EP1877390A1 (de) 2008-01-16
CN101208314B (zh) 2010-12-08
MX2007013352A (es) 2008-03-26
DE602006013115D1 (de) 2010-05-06

Similar Documents

Publication Publication Date Title
ATE459621T1 (de) Benzisoxazolpiperidinverbindungen und verfahren zu deren anwendung
DE602005024599D1 (de) Verbindungen modulierende thrombopoietinaktivität und verfahren
DE602004004267D1 (de) Formtrennmittelzusammensetzung und verfahren damit
CY1113386T1 (el) Αναστολεις πρωτεασωματος
ATE460403T1 (de) Verbindungen und verfahren zur modulierung von fx-rezeptoren
DE602005026984D1 (de) Chinolin-derivate zur behandlung von latenter tuberkulose
DE602006017980D1 (de) 3,4-substituierte pyrrolidin-derivate zur behandlung von hypertonie
AT9566U3 (de) Kopierfräseinrichtung zur herstellung von zahntechnischen werkstücken
ATE548374T1 (de) 2'-fluor-2'-desoxytetrahydrouridine als cytidindeaminaseinhibitoren
DK1879573T3 (da) Modulatorer af indolamin 2,3-dioxygenase og fremgangsmåder til anvendelse deraf
DE602005004280D1 (de) Verfahren zum ziehen von sic-einkristallen und sic-einkristall
NO20083002L (no) Fremgangsmate for anvendelse av CD40-bindende forbindelser
DE602005022123D1 (de) Vorrichtung und verfahren zur beförderung von bohrklein
DE602005005810D1 (de) Verwendung von substituierten chinolin-derivaten zur behandlung von arzneimittelresistenten mycobakteriellen erkrankungen
ATE473744T1 (de) Modifizierte pyrimidin-glucocorticoid-rezeptor- modulatoren
DE602006010400D1 (de) Olanzapin-analoga und verfahren zu ihrer verwendung
DE602005003648D1 (de) Derivate von alkylpiperazin- und alkylhomopiperazincarboxylaten, verfahren zu deren herstellung und deren verwendung als inhibitoren des faah-enzyms
DE602006015182D1 (de) Zusammensetzung und verfahren zur kontrolle von insekten
DE602006005437D1 (de) Verfahren und Vorrichtung zum Herstellung von Bauteilen
ATE504585T1 (de) Heterocyclische verbindungen, zusammensetzungen damit und verfahren zu ihrer anwendung
ATE462701T1 (de) Verfahren zur herstellung von 4-(phenoxy-5-methyl-pyrimidin-4-yloxy)piperidin 1-carboxylsäure- derivaten und damit zusammenhängenden verbindungen
ATE439831T1 (de) Stabile kristalline form von bifeprunoxmesylat, dosierungsformen davon und verfahren zu deren verwendung
ATE413875T1 (de) Zusammensetzungen enthaltend levetiracetam und verfahren zu deren herstellung.
SG136953A1 (en) Aqueous cleaning composition and method for using same
ATE495735T1 (de) Verfahren und zusammensetzung, die immunomodulatorische verbindungen zur behandlung von mit niedrigen plasmaleptin-spiegeln in zusammenhang stehenden störungen verwenden

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1877390

Country of ref document: EP